Author Archives: mikebriggs1910

About mikebriggs1910

Mike Briggs obtained his PhD at the MRC Clinical Research Centre, Harrow, studying the genetic basis of Osteogenesis Imperfecta. He undertook postdoctoral work at UCLA identifying the genetic basis of chondrodysplasias. In 1996 Mike moved to Manchester as an AR-UK Fellow to continue studying disease mechanisms in chondrodysplasia. In 2004 he was awarded a Wellcome Trust Senior Research Fellowship that was renewed in 2009. In 2012 he was appointed Professor of Skeletal Genetics in the Institute of Genetic Medicine at Newcastle University and continues to work on disease mechanisms in chondrodysplasia with a focus on identifying novel therapeutics for these rare diseases. Mike has been instrumental in establishing several European consortia for the diagnosis and research of rare skeletal diseases. These have included European Skeletal Dysplasia Network, EuroGrow and most recently SYBIL, a large-scale FP7 funded project involving 18 partners over 5 years.

Skeletal genetics on tour 2018

2018 looks to be filling up with conferences that members of the ‘rare disease section’ of the skeletal research group at IGM will be presenting at


In February it is rare disease day and in addition to IGM’s annual flagship Genetics Matters event, Mike will be talking at Findacure’s 2018 Drug Repurposing for Rare Diseases Conference.


In April Kasia will be talking at the Bone Research Society and the OARSI young investigators pre-congress workshop entitled “Lessons from Rare Diseases in Bone & Cartilage”.


In May Mike will be talking at pre-congress sessions at The European Calcified Tissue Society (ECTS) Annual Meeting. He will present at a working shop on cartilage pathophysiology and EU consortia.


In June Mike will be speaking within the Rare Bone Disease Workshop, taking place during the Bone Research Society Annual Meeting being held at the University of Winchester, 27-29 June 2018.


In July Mike will be talking at Matrix Biology Europe 2018.